Christian Schade - Feb 7, 2024 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role: Director
Signature: /s/ Barbara Chan as Attorney-in-Fact for Christian S. Schade
Stock symbol: OMGA
Transactions as of: Feb 7, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/9/2024, 04:57 PM
Previous filing: Jul 12, 2023
Next filing: May 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OMGA	Stock Option (Right to Buy)	Award	$0	+513K		$0.00	513K	Feb 7, 2024	Common Stock	513K	$3.59	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vested and became exercisable as to 14.28% of the underlying shares on February 7, 2024 and vests and will become exercisable in thirty-six (36) substantially equal monthly installments thereafter, such that the option shall be fully vested and exercisable on February 7, 2027, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date.

Content

The option vested and became exercisable as to 14.28% of the underlying shares on February 7, 2024 and vests and will become exercisable in thirty-six (36) substantially equal monthly installments thereafter, such that the option shall be fully vested and exercisable on February 7, 2027, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date.